I already told you last time it was a totally different company over 5 years ago. Do you know how much time it takes for a product to reach commercialisation??? IMU has a lot more fund and resource now so they can speed their clinical trials compared to when they only had HER-Vaxx in their pipeline. Why do you think company usually get T/O by BP when their IP are end of Ph2 clinical trial? BP have the fund and resource to take the IP to end of Ph3 and then FDA approval and commercialisation.
Why IMU is a multi multi bagger, page-24744
-
- There are more pages in this discussion • 2,114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 5.0¢ | 4.8¢ | $458.6K | 9.378M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1039220 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 5436876 | 20 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |